Army Researchers Developing Zika Vaccine

Army Researchers Developing Zika Vaccine

Harvard and Walter Reed scientists collaborate in an effort to protect humans from a mosquito-borne virus. by Col. Nelson L. Michael and Col. Stephen J. Thomas Researchers at Walter Reed Army Institute of Research (WRAIR) in Silver Spring, Maryland, moved quickly to develop and begin testing a Zika vaccine candidate early this year. The fast-moving virus, which is transmitted by infected mosquitos and through sexual contact, alarmed the world as it spread through South and Central America, causing serious birth defects. A preclinical study published June 28 in the journal Nature indicated the feasibility of a vaccine to prevent Zika infection in humans. The study was completed by WRAIR and […]

Research Resource

Research Resource

Rapid detection devices for pathogen vectors are case study in leveraging small business innovation funding   By Maj. Vanessa R. Melanson   When military forces arrive in a new operational area, military preventive medicine personnel—preventive medicine specialists, entomologists and environmental science engineers—assess the environment, identify health threats and propose mitigations. Vector-borne diseases are one of the primary readiness threats, and the arthropods (insects and arachnids) that transmit pathogens to people account for about 60 percent of the military’s priority pathogens list. Vector pathogen detection (VPD) provides military preventive medicine personnel the information necessary to implement specific vector-control measures and disease prevention countermeasures. VPD can minimize disease by sampling arthropods for […]

WRAIR Investigator Receives Key Support to Develop Combined Anti-Heroin and HIV Vaccine

WRAIR Investigator Receives Key Support to Develop Combined Anti-Heroin and HIV Vaccine

Dr. Gary R. Matyas of the Walter Reed Army Institute of Research (WRAIR) has been selected as the 2012 recipient of the National Institute on Drug Abuse (NIDA) Avant-Garde Award for Medications Development. Matyas proposes to develop an effective, safe, and easily manufactured combination anti-heroin/human immunodeficiency virus (HIV) vaccine that could treat heroin addiction while also preventing HIV infection in those receiving the vaccine. Matyas will receive $1 million per year for five years to support his research. He is a U.S. Army civilian at WRAIR in Silver Spring, MD. NIDA, part of the National Institutes of Health, announced the award July 25 as part of its Avant-Garde Award Program […]